Ergoteles’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,956
Closed -$413K 1573
2022
Q2
$413K Buy
+1,956
New +$413K 0.01% 926